Brief: Hanall Biopharma Q2 Operating Loss 3 Billion Won
25/07/2024 08:30
Hanall Biopharma Co Ltd 009420.KS :
* HANALL BIOPHARMA: Q2 OPERATING LOSS 3 BILLION WON
Source text for Eikon: ID:
Further company coverage: 009420.KS
Recent news on Hanall Biopharma
See all newsQ2 2026 Operating Profit Up 567.4% QoQ, 388.5% YoY To Won 5.60 Billion
Brief: Hanall Biopharma Co Icc Rules Licensing Deal With Harbour Biomed Continues To Be Effective
Brief: Hanall Biopharma Q1 Operating Profit 839 Million Won, Swings To Profit From Year Earlier
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies